Advances in Immunology
- 1st Edition, Volume 163 - September 13, 2024
- Latest edition
- Editors: Frederick W. Alt, Kenneth Murphy
- Language: English
Advances in Immunology, Volume 163, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immuno… Read more
Advances in Immunology, Volume 163, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology. Sample chapters include The role of autophagy in RIP1 mediated cell death and intestinal inflammation, IL-17 family cytokines in inflammatory or autoimmune kin diseases, and more.
- Presents current developments and comprehensive reviews in immunology
- Provides the latest in a longstanding and respected serial on the subject matter
- Focuses on recent advances in the field of immunology
Immunologists and infectious disease specialists, cell biologists and hematologists
1. Chapter title yet to be determined
Dusan Bogunovic
2. The role of autophagy in RIP1 mediated cell death and intestinal inflammation
Domagoj Vucic and Yujung Michelle Lee
3. IL-17 family cytokines in inflammatory or autoimmune kin diseases
Yuping Lai and Baida Kong
Dusan Bogunovic
2. The role of autophagy in RIP1 mediated cell death and intestinal inflammation
Domagoj Vucic and Yujung Michelle Lee
3. IL-17 family cytokines in inflammatory or autoimmune kin diseases
Yuping Lai and Baida Kong
- Edition: 1
- Latest edition
- Volume: 163
- Published: September 13, 2024
- Language: English
FA
Frederick W. Alt
Frederick W. Alt is a Howard Hughes Medical Institute (HHMI) Investigator and Director of the Program in Cellular and Molecular Medicine (PCMM) at Boston Children's Hospital (BCH). He is the Charles A. Janeway Professor of Pediatrics and Professor of Genetics at Harvard Medical School. He works on elucidating mechanisms that generate antigen receptor diversity and, more generally, on mechanisms that generate and suppress genomic instability in mammalian cells, with a focus on the immune and nervous systems. Recently, his group has developed senstive genome-wide approaches to identify mechanisms of DNA breaks and rearrangements in normal and cancer cells. He has been elected to the U.S. National Academy of Sciences, the U.S. National Academy of Medicine, and the European Molecular Biology Organization. His awards include the Albert Szent-Gyorgyi Prize for Progress in Cancer Research, the Novartis Prize for Basic Immunology, the Lewis S. Rosensteil Prize for Distinugished work in Biomedical Sciences, the Paul Berg and Arthur Kornberg Lifetime Achievement Award in Biomedical Sciences, and the William Silan Lifetime Achievement Award in Mentoring from Harvard Medical School.
Affiliations and expertise
Investigator and Director, Program in Cellular and Molecular Medicine, Howard Hughes Medical Institute Research Laboratories, The Children's Hospital, Boston, MA, USAKM
Kenneth Murphy
Kenneth M. Murphy works in Washington University School of Medecine, USA.
Affiliations and expertise
Washington University School of Medecine, USARead Advances in Immunology on ScienceDirect